Dr. Sanket Mehta

Genetic testing and genomic profiling are becoming increasingly important in liver cancer and bile duct cancer treatment. Advanced testing can help identify specific genetic mutations that may open the door to personalized and targeted treatment options beyond conventional chemotherapy. In conditions such as hepatocellular carcinoma and cholangiocarcinoma, genomic profiling may detect mutations linked to precision therapies and targeted medicines. Genetic testing may also be considered in younger patients or individuals with a strong family history of cancer to identify inherited cancer risks. Personalized cancer care helps doctors create treatment plans tailored to each patient’s condition, improving decision-making and expanding available treatment options. Awareness about genetic testing and precision oncology is an important step toward modern cancer care and informed treatment planning. 📢 Share this video to spread awareness about genetic testing and personalized treatment approaches in liver and bile duct cancers. #GeneticTesting #LiverCancer #BileDuctCancer #Cholangiocarcinoma #PrecisionOncology #TargetedTherapy #CancerAwareness #PersonalizedMedicine #OncologyCare May 12, 2026 Learn more